Dubai: The Ministry of Health and Prevention (MoHAP) has unveiled today details of the August Schedule of its Visiting Consultants Program, which features an elite group of medical consultants including: Interventional Cardiology, Rheumatology, adult & pediatric Neurosurgery, as well as Pulmonology.
August Visiting Consultants will visit Al Qassimi Hospital Sharjah, Obaidullah Hospital Ras Al Khaimah, and Fujairah Hospital.
In this context, Dr. Sultan Al Sharif, Director of the MoHAP’s Visiting Consultants Office, said: “MoHAP is always keen on the diversification of consultants’ specialties and the selection of the best medical competencies to fulfill our patients’ needs at MoHAP’s hospitals. Through this program, we are striving to achieve the best outcomes, in line with MoHAP’s strategy in terms of providing comprehensive and integrated healthcare services as per the international standards.”
Al Sharif shed light on the importance of the Visiting Consultants Program in terms of attracting doctors from the world’s pioneer countries in the healthcare field. This includes, but not limited to, USA, Finland, Japan, Scotland, Saudi Arabia, and Japan.
-Ends-
For further information, please contact:
Heba Alshahed
Misbar Communications
00971505784522
heba.alshahed@misbar-me.com
Osama Al Ansari
Misbar Communications
00971509194522
Osama@misbar-me.com
Mahmoud Soliman
Misbar Communications
00971505874522
mahmoud.soliman@misbar-me.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
